Biosimilars player Alvotech has offloaded millions more of its stock, raising approximately $137m at current exchange rates via an overseas private placement directed solely into its native Iceland to professional clients.
Completed on 22 January, the private placement is expected to be closed and settled on 10 February,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?